|

Fingolimod 0.5 milligram (mg) [Gilenya] Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Medical University of South Carolina1

Indications

  • Small Cell Lung Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Charleston, South Carolina1 trial

Phase 2 Study of Fingolimod in Lung Cancers

Hollings Cancer Center at Medical University of South Carolina

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.